In a comparison of the control with cancer group (grade 4), the 5-marker panel (CCT3, PCMT1, TKT, TOMM34, UBA1) showed better sensitivity (0.90 and 0.90), specificity (0.93 and 1.00), error rate (8 and 4%), and AUC value (0.94 and 0.96) than the best single marker (TOMM34). This evidence concerns the gene PCMT1 and cancer.